Eight pedigrees with homozygous or compound heterozygous variants of MPZL2 from a hearing loss patient cohort of 3272 who underwent genetic testing from December 2015 to November 2022 in the Genetic Testing Center of Chinese PLA General Hospital, were included in this study. Here, MPZL2 is linked to hearing loss disorder.